{"id":136414,"date":"2025-09-05T09:57:55","date_gmt":"2025-09-05T02:57:55","guid":{"rendered":"https:\/\/hmm88i.com\/drug\/?post_type=product&p=136414"},"modified":"2025-09-05T10:01:18","modified_gmt":"2025-09-05T03:01:18","slug":"nebicard-2-5","status":"publish","type":"product","link":"https:\/\/hmm88i.com\/drug\/nebicard-2-5\/","title":{"rendered":"Nebicard 2.5"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, <\/strong>d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng<\/strong><\/a> gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n s\u1ea3n ph\u1ea9m thu\u1ed1c Nebicard-2.5<\/a> \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Torrent Pharmaceuticals Ltd., c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 890110352525 (S\u0110K c\u0169: VN-21141-18).<\/strong><\/p>\n

Nebicard-2.5 l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n

Th\u00e0nh ph\u1ea7n<\/h3>\n

Thu\u1ed1c Nebicard-2.5<\/strong> c\u00f3 ch\u1ee9a th\u00e0nh ph\u1ea7n: Nebivolol (d\u01b0\u1edbi d\u1ea1ng Nebivolol hydrochloride) 2,5mg<\/p>\n

D\u1ea1ng b\u00e0o ch\u1ebf: Vi\u00ean n\u00e9n<\/p>\n

Tr\u00ecnh b\u00e0y<\/h3>\n

S\u0110K: 890110352525 (S\u0110K c\u0169: VN-21141-18)<\/p>\n

Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 5 v\u1ec9 x 10 vi\u00ean<\/p>\n

Xu\u1ea5t x\u1ee9: \u1ea4n \u0110\u1ed9<\/p>\n

H\u1ea1n s\u1eed d\u1ee5ng: 36 th\u00e1ng<\/p>\n

T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Nebicard-2.5<\/h2>\n

C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n

Ho\u1ea1t ch\u1ea5t Nebivolol thu\u1ed9c nh\u00f3m ch\u1eb9n beta 1, th\u00e2n n\u01b0\u1edbc, th\u01b0\u1eddng \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng d\u01b0\u1edbi d\u1ea1ng h\u1ed7n h\u1ee3p racemic \u0111\u1ed3ng ph\u00e2n D v\u00e0 L v\u1edbi t\u1ef7 l\u1ec7 b\u1eb1ng nhau. Ho\u1ea1t ch\u1ea5t \u0111\u1ed1i kh\u00e1ng c\u1ea1nh tranh c\u00f3 t\u00ednh ch\u1ecdn l\u1ecdc cao \u0111\u1ed1i v\u1edbi receptor beta 1, t\u00e1c \u0111\u1ed9ng nh\u1eb9 t\u1edbi m\u1ea1ch m\u00e1u, b\u1ea3o v\u1ec7 kh\u1ea3 n\u0103ng ho\u1ea1t \u0111\u1ed9ng c\u1ee7a th\u1ea5t tr\u00e1i, gi\u1ea3m ti\u1ec1n g\u00e1nh h\u1eadu g\u00e1nh, duy tr\u00ec cung l\u01b0\u1ee3ng tim, t\u1eeb \u0111\u00f3 gi\u00fap \u0111i\u1ec1u tr\u1ecb t\u0103ng huy\u1ebft \u00e1p.<\/p>\n

\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n

H\u1ea5p thu: Nebivolol h\u1ea5p thu nhanh qua \u0111\u01b0\u1eddng ti\u00eau h\u00f3a, n\u1ed3ng \u0111\u1ed9 \u0111\u1ea1t \u0111\u1ec9nh trong huy\u1ebft t\u01b0\u01a1ng sau kho\u1ea3ng \u00bd -2 gi\u1edd, s\u1ef1 h\u1ea5p thu kh\u00f4ng b\u1ecb \u1ea3nh h\u01b0\u1edfng b\u1edfi th\u1ee9c \u0103n. Sinh kh\u1ea3 d\u1ee5ng thu\u1ed1c kho\u1ea3ng 12% (\u0111\u1ed1i t\u01b0\u1ee3ng chuy\u1ec3n h\u00f3a t\u1ed1t) v\u00e0 96% (\u0111\u1ed1i t\u01b0\u1ee3ng chuy\u1ec3n h\u00f3a k\u00e9m)<\/p>\n

Ph\u00e2n b\u1ed1: T\u1ef7 l\u1ec7 li\u00ean k\u1ebft c\u1ee7a Nebivolol v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng kho\u1ea3ng 98,1% (SRRR) v\u00e0 97,9% (RSSS)<\/p>\n

Chuy\u1ec3n h\u00f3a: Nebivolol chuy\u1ec3n h\u00f3a m\u1ea1nh t\u1ea1i gan<\/p>\n

Th\u1ea3i tr\u1eeb: Th\u1eddi gian b\u00e1n th\u1ea3i trung b\u00ecnh c\u1ee7a thu\u1ed1c kho\u1ea3ng 10 gi\u1edd.<\/p>\n

Thu\u1ed1c Nebicard-2.5 \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n

Thu\u1ed1c Nebicard-2.5<\/strong> \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh s\u1eed d\u1ee5ng trong \u0111i\u1ec1u tr\u1ecb cho b\u1ec7nh nh\u00e2n cao huy\u1ebft \u00e1p<\/p>\n

\"Nebicard-2.5
Nebicard-2.5 \u0111i\u1ec1u tr\u1ecb t\u00ecnh tr\u1ea1ng t\u0103ng huy\u1ebft \u00e1p<\/figcaption><\/figure>\n

Li\u1ec1u d\u00f9ng c\u1ee7a thu\u1ed1c Nebicard-2.5<\/h2>\n

Li\u1ec1u d\u00f9ng<\/h3>\n

Li\u1ec1u d\u00f9ng: 5 mg\/ng\u00e0y, c\u00f3 th\u1ec3 d\u00f9ng trong b\u1eefa \u0103n<\/p>\n

C\u00e1ch d\u00f9ng<\/h3>\n

Thu\u1ed1c Nebicard-2.5 d\u1ea1ng vi\u00ean n\u00e9n, s\u1eed d\u1ee5ng \u0111\u01b0\u1eddng u\u1ed1ng<\/p>\n

Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c Nebicard-2.5 trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/h2>\n